The Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) is a major research centre in Scotland and is amongst the UK’s top Schools of Pharmacy. They have a wide range of state-of-the-art research facilities with research focused on ‘New Medicines, Better Medicines & Better Use of Medicines’. SIPBS is home to Continuous Manufacturing & Crystallisation (CMAC), the Cancer Research UK Formulation Unit, an SFC-funded Industrial Biotechnology Innovation Centre (IBioIC), now the Rapid Prototyping Centre and the Centre for Biophotonics.  SIPBS also hosts the Drug Discovery company, Mironid Ltd targeting various diseases for therapeutic intervention.